Satellos Bioscience Stock Today
| MSCL Stock | 17.27 0.58 3.25% |
PerformanceSolid
| Odds Of DistressLow
|
Satellos Bioscience is selling at 17.27 as of the 4th of March 2026; that is 3.25% down since the beginning of the trading day. The stock's open price was 17.85. Satellos Bioscience has less than a 15 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. Satellos Bioscience has reported 12 for 1 split on 30th of January 2026. The performance scores are derived for the period starting the 4th of December 2025 and ending today, the 4th of March 2026. Click here to learn more.
Category Healthcare |
Moving together with Satellos Stock
Moving against Satellos Stock
Satellos Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Satellos Bioscience's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Satellos Bioscience or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, CoFounder | Francis MBA |
| Business Concentration | Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors) |
Satellos Bioscience (MSCL) is traded on Toronto Exchange in Canada and employs 14 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 368.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Satellos Bioscience's market, we take the total number of its shares issued and multiply it by Satellos Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Satellos Bioscience operates under Healthcare sector and is part of Biotechnology industry. The entity has 20.63 M outstanding shares of which 24.7 K shares are now shorted by private and institutional investors with about 0.41 days to cover all short positions.
Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations.
Check Satellos Bioscience Probability Of Bankruptcy
Ownership AllocationSatellos Bioscience shows a total of 20.63 Million outstanding shares. Satellos Bioscience has 6.2 % of its outstanding shares held by insiders and 6.17 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Satellos Ownership Details
Satellos Bioscience Risk Profiles
Although Satellos Bioscience's alpha and beta are two of the key measurements used to evaluate Satellos Bioscience's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.5 | |||
| Semi Deviation | 2.96 | |||
| Standard Deviation | 4.5 | |||
| Variance | 20.26 |
Satellos Stock Against Markets
Satellos Stock Analysis Notes
The company had not issued any dividends in recent years. Satellos Bioscience had 1:12 split on the 30th of January 2026. To find out more about Satellos Bioscience contact Francis MBA at 647-660-1780 or learn more at https://satellos.com.Satellos Bioscience Investment Alerts
| Satellos Bioscience appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (28.1 M) with loss before overhead, payroll, taxes, and interest of (16.68 M). | |
| Satellos Bioscience has accumulated about 40.07 M in cash with (24.98 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Equity Trading Insights - Stock Traders Daily |
Satellos Largest EPS Surprises
Earnings surprises can significantly impact Satellos Bioscience's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-03-27 | 2023-12-31 | -0.01 | -0.07 | -0.06 | 600 | ||
2025-05-13 | 2025-03-31 | -0.6 | -0.67 | -0.07 | 11 | ||
2025-08-13 | 2025-06-30 | -0.6 | -0.5 | 0.1 | 16 |
Satellos Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 368.19 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Satellos Bioscience's market, we take the total number of its shares issued and multiply it by Satellos Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Management Efficiency
Satellos Bioscience has return on total asset (ROA) of (0.5425) % which means that it has lost $0.5425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8759) %, meaning that it generated substantial loss on money invested by shareholders. Satellos Bioscience's management efficiency ratios could be used to measure how well Satellos Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Leadership effectiveness at Satellos Bioscience is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 4th of March, Satellos Bioscience has the Risk Adjusted Performance of 0.2122, semi deviation of 2.96, and Coefficient Of Variation of 369.71. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Satellos Bioscience, as well as the relationship between them.Satellos Bioscience Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Satellos Bioscience Tanh Of Price Series is a hyperbolic price transformation function.
Satellos Bioscience Outstanding Bonds
Satellos Bioscience issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Satellos Bioscience uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Satellos bonds can be classified according to their maturity, which is the date when Satellos Bioscience has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Satellos Bioscience Predictive Daily Indicators
Satellos Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Satellos Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2582.38 | |||
| Daily Balance Of Power | (0.25) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 17.81 | |||
| Day Typical Price | 17.63 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (0.83) | |||
| Period Momentum Indicator | (0.58) | |||
| Relative Strength Index | 58.45 |
Satellos Bioscience Forecast Models
Satellos Bioscience's time-series forecasting models are one of many Satellos Bioscience's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Satellos Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in Satellos Bioscience without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Satellos Bioscience Corporate Management
Elected by the shareholders, the Satellos Bioscience's board of directors comprises two types of representatives: Satellos Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Satellos. The board's role is to monitor Satellos Bioscience's management team and ensure that shareholders' interests are well served. Satellos Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Satellos Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MBA | Chief Officer | Profile | |
| Philip MA | Chief Officer | Profile | |
| CPA CMA | Head Strategy | Profile | |
| Ryan Mitchell | Senior Development | Profile | |
| Desiree Chan | Chief Staff | Profile |
Other Information on Investing in Satellos Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.